News
1 October 2026
Fonko Strengthens Indonesia’s Oncology Industry Capacity
JAKARTA — PT Fonko International Pharmaceuticals has recorded several key milestones in the development of oncology drug manufacturing in Indonesia. These achievements include securing European Union Good Manufacturing Practice (EU GMP) certification in 2025, developing a range of "first copy" products for cancer therapy, and obtaining halal certification for its…
25 September 2026
Consistently Maintaining Halal Standards, Dexa Group Wins IHYA 2026
TANGERANG — PT Ferron Par Pharmaceuticals, a member of Dexa Group, has won the 2026 Indonesia Halal Industry Award (IHYA) from the Ministry of Industry of the Republic of Indonesia in the Large Industrial Enterprise Category, Subcategory of Best Pharmaceuticals and Traditional Medicines. This award recognizes Dexa Group’s consistency in…
24 September 2026
From Medications to Facilities, Ferron Strengthens Support for Cancer Patients
JAKARTA — Indonesia recorded 474,083 new cases and 283,299 deaths due to cancer, according to 2024 Global Cancer Observatory (GLOBOCAN) data. This situation underscores the critical role of Ferron Par Pharmaceuticals in expanding its support for cancer patients—from delivering access to medications to strengthening chemotherapy support facilities through the provision…
13 May 2022
HerbaASIMOR Products Aid in the Reduction of Stunting Rates
According to the Indonesia Nutrition Status Survey (SSGI), in 2021, the prevalence of stunting in Indonesia will be 24.4 percent, a 6.4 percent decrease from 30.8 percent in 2018. To meet the goal of reducing stunting prevalence to 14 percent by 2024, the Population Agency and the National Family Planning…
2 May 2022
Dexa Group Donates Cancer Medicines to aid Sri Lanka’s Economic and Health Crisis
The economic crisis that hit Sri Lanka caused a lack of supplies of medicines in the country and encouraged the concern of pharmaceutical companies in Indonesia to donate medicines and medical devices, including Dexa Group. The World Health Organization authorities submitted the request to the Indonesian government through the Indonesian…
28 March 2022
Dexa Group Optimizing the Potential of the Domestic Market to Improve the Quality of Life for the Elderly
As the world's fifth-largest elderly population, Indonesia offers a substantial market potential for health goods and services for the elderly. As a result, to enhance the quality of life of the elderly in Indonesia, innovation and research in geriatrics, particularly by native researchers, must be supported. This statement was conveyed…
23 March 2022
Dexa Group’s High TKDN Products Become Pharmaceutical Products in Business Matching
Dexa Group is one of the pharmaceutical companies that take part in Business Matching activities organized by the Ministry of Industry to maximize the purchase of domestic products. The event, which took place on the 22nd until 24th of March 2022 in Nusa Dua, Bali, continued the Bangga Buatan Indonesia…
18 March 2022
Dexa Group Attends the Inauguration of the ‘Pengabdian Dokter Indonesia’ Monument in Memory of Indonesian Doctors Who Served During the Pandemic
The Indonesian Doctors Association inaugurated the erection of a monument named "Pengabdian Dokter Indonesia" to remember the services of doctors who died to preserve the lives of Indonesians while dealing with COVID-19. Dexa Group took part in the establishment and inauguration of the monument, which took place on Thursday, March…
9 March 2022
Indonesian Indigenous Modern Medicines, Green Pharmacy Implementation for Strengthening Global Health at the T20 Forum
The local healthcare industry is the backbone of healthcare services, serving as a solid support structure for the country's requirements. Green Pharmacy is a notion that became the idea of the Indonesian pharmaceutical business by exploiting natural biodiversity in the form of Indonesian Indigenous Modern Medicines items manufactured using modern…
25 February 2022
Journey with Pinisi, OMAI Expedition Donates Medicines for Public Health in South Sulawesi
To improve public health and handle stunting issues in South Sulawesi, Dexa Group donated Indonesian Indigenous Modern Medicines (OMAI). The OMAI donation was symbolically handed over during the OMAI Expedition at the Bangga Buatan Indonesia & Bangga Wisata Indonesia Sulawesi Selatan 2022 South Sulawesi 2022 event at Losari Beach Pavilion,…